Library / Laws / 118th Congress / Senate Bills / S. 5029
S. 5029
To amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2024-09-12 | 4.0K | ⠃⠗⠋ |